Aquinox to Host R&D Day in New York on Wednesday, October 7th

Aquinox Pharmaceuticals, Inc. AQXP announced that it will host an R&D Day in New York City on Wednesday, October 7th from 8:30 AM to 10:00 AM Eastern Time. This event will provide an opportunity to hear from a distinguished clinical expert on bladder pain syndrome/interstitial cystitis (BPS/IC), a debilitating disease affecting millions in the U.S. Aquinox will also be reviewing the full data from its recently completed LEADERSHIP trial and provide an update on the clinical development plans for AQX-1125 in BPS/IC. Senior members of Aquinox's executive team will be in attendance, including David Main, President & CEO and Dr. Stephen Shrewsbury, Senior VP of Clinical Development and Chief Medical Officer. Also attending will be Dr. Robert Evans M.D., Associate Professor of Urology at Wake Forest Baptist Health University and Clinical Instructor, Wake Forest School of Medicine Department of Urology. Dr. Evans has been a practicing urologist for more than 25 years while serving on the American Urologic Association guidelines committee for interstitial cystitis as well as the Medical Advisory Board and the Board See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsManagementPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!